Denamycin is a new antibiotic obtained from the cultured filtrate and mycelium of Streptomyces sp. No. 8756-CC2. It is purified on silica gel column chromatography followed by crystallization from organic solvents. In the course of screening studies of search for the inhibitory substance of nucleic acid biosyntheses, the strains of Streptomyces whose cultured broth did not show antibacterial inhibition zones by the usual cup plate assay method of antibiotics were selected. The inhibitory effect of these cultured broths on the biosyntheses of DNA and RNAand on the bacterial growth was measured using Bacillus subtilis Marburg strain 168 (thymine-less, indole-less) according to the method described by Tanaka and others1).
The antibiotic was first detected in a cultured broth of Streptomyces sp. No. 8756-CC2, which exhibited no antimicrobial inhibition zones on a usual cup plate method,, but inhibited the incorporations of 3H-thymine and 14C-uracil into the bacterial cells of Bacillus subtilis 168 and the growth of the Ehrlich ascites carcinoma in mice.
The antibiotic nameddenamycinwas extracted with organic solvents from the filtrate and mycelium, and was purified by column chromatography and recrystallization. The isolation and characterization and biological properties of denamycin are described in the present paper. hours at 27°C in a medium for seed culture consisting of 1.0% glycerin and 1.0% meat extract. The antibiotic was produced in shake-flask fermentation in a medium composed of 1.5% glucose, 1.0 % glycerin, 1.0% meat extract, 1.0% peptone and 0.04% CaCO3, pH adjusted at 7.2 before sterilization. Maximumyield was obtained by incubation for 72 hours at 27°C on a rotary shaker in 500-ml flasks containing 100 ml of the mediumand 2 ml of the seed culture. The large scale fermentation was attempted to produce the antibiotic in jar fermentor. It was difficult to obtain a good yield in usual cultural conditions on account of its instability to aeration. A successful result was obtained as follows : Six hundred ml of the seed culture was inoculated to the 30-liter jar fermentor containing 15 liters of the production medium.Aeration was maintained for 24 hours at a rate of 1/1 vol/min with 400 rpm agitation at 27°C. Thereafter, aeration was decreased to a rate of 0.5/1 vol/min with agitation of 200-300 rpm at the same temperature. Maximumpotency of the antibiotic was obtained after 72 hours.
Assay Methods of Denamycin A method described by Tanaka and others13 has been applied to determine the The infrared absorption spectrum in KBr tablet is shown in Fig. 2 , which shows characteristic bands at 3550 cm x corresponding to hydroxyl group ; 3440 cm"1 and 3370 cm"1 to phenolic hydroxyl group; 1715, 1645 and 1610 cm"1 to carbonyl.
The catalytic hydrogenation of denamycin was carried out in methanol with platinum dioxide at atmospheric pressure.
It consumed a reasonable amount of hydrogen, and the product was also unstable to ultraviolet light and aeration.
Biological Properties of Denamycin A method described by Tanaka and others1} has been applied to test the effects of denamycin on the bacterial growth and on the nucleic acid syntheses of Bacillus subtilis 168. The results are shown in Fig. 3 . Denamycin inhibited about 93% of the incorporation of 14C-uracil into the <4C-ura(DM,0.4pg/ml) //. 3 cc 2.
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